These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11309343)

  • 1. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
    Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
    Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
    Mayer A; Höckel M; Wree A; Vaupel P
    Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
    Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
    Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
    J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
    Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
    Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?
    Mayer A; Höckel M; Vaupel P
    Strahlenther Onkol; 2006 Sep; 182(9):501-10. PubMed ID: 16944371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
    Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
    Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
    Airley RE; Mobasheri A
    Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
    Cooper R; Sarioğlu S; Sökmen S; Füzün M; Küpelioğlu A; Valentine H; Görken IB; Airley R; West C
    Br J Cancer; 2003 Sep; 89(5):870-6. PubMed ID: 12942120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
    Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
    Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
    Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.